Reproducibility of Cirrus Optical Coherence Tomography Measurements

This study has been completed.
Sponsor:
Information provided by:
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
ClinicalTrials.gov Identifier:
NCT00643422
First received: March 22, 2008
Last updated: July 21, 2008
Last verified: July 2008
  Purpose

In this study the reproducibility of optical coherence tomography measurements should be evaluated.


Condition Intervention
Healthy
Device: Cirrus™ HD-OCT, Carl Zeiss Meditec AG

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Reproducibility of Retinal Thickness and Volume Measurements Determined With the Cirrus Spectral Domain OCT

Further study details as provided by The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery:

Primary Outcome Measures:
  • retinal thickness [ Time Frame: two ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • retinal volume [ Time Frame: two ] [ Designated as safety issue: No ]

Estimated Enrollment: 16
Groups/Cohorts Assigned Interventions
Observation Device: Cirrus™ HD-OCT, Carl Zeiss Meditec AG
the retinal thickness and volume is determined on two different days with the Cirrus™ HD-OCT.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

attendants of health care center

Criteria

Inclusion Criteria:

  • 18 years of age or older
  • best corrected visual acuity of at least 20/25
  • clear optical media

Exclusion Criteria:

  • any kind of retinal pathology
  • any kind of opacity of optical media
  • any kind of intraocular surgery
  • spherical refraction of more than 5 diopters
  • cylindrical refraction of more than 3 diopters
  • amblyopia
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00643422

Locations
Austria
Rudolf Foundation Clinic
Vienna, Austria, 1030
Sponsors and Collaborators
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
  More Information

Publications:

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Stefan Hagen, MD, Ludwig Boltzmann Institute of retinology and biomicroscopic laser surgery
ClinicalTrials.gov Identifier: NCT00643422     History of Changes
Other Study ID Numbers: Cirrus_OCT_0308
Study First Received: March 22, 2008
Last Updated: July 21, 2008
Health Authority: Austria: Ethikkommission

Keywords provided by The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery:
normal eyes

ClinicalTrials.gov processed this record on September 18, 2014